Literature DB >> 22044329

Mass-to-splenic volume ratio and splenic weight as a percentage of body weight in dogs with malignant and benign splenic masses: 65 cases (2007-2008).

Mary Jo Mallinckrodt1, Sharon D Gottfried.   

Abstract

OBJECTIVE: To determine whether mass-to-splenic volume ratio or splenic weight as a percentage of body weight was significantly different between dogs with benign versus malignant splenic masses.
DESIGN: Retrospective case series. ANIMALS: 65 dogs that underwent splenectomy. PROCEDURES: Medical records of dogs examined between October 2007 and June 2008 because of a splenic mass were reviewed. Information obtained included dog age, breed, and weight; whether hemoperitoneum was present; splenic weight and dimensions (length, width, and height) at the time of splenectomy; dimensions (length, width, and height) of the splenic mass; and histologic diagnosis. Information on survival time was recorded when available.
RESULTS: 30 (46%) dogs had hemangiosarcoma, 10 (15%) had other types of malignant masses, and 25 (39%) had benign masses. Dogs with benign splenic masses had a significantly higher mean mass-to-splenic volume ratio and higher mean splenic weight as a percentage of body weight than did dogs with hemangiosarcoma. CONCLUSIONS AND CLINICAL RELEVANCE: Results suggested that mass-to-splenic volume ratio and splenic weight as a percentage of body weight may be useful in differentiating between hemangiosarcoma and benign lesions in dogs with splenic masses.

Entities:  

Mesh:

Year:  2011        PMID: 22044329     DOI: 10.2460/javma.239.10.1325

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  9 in total

1.  Outcome and prognostic factors for dogs with a histological diagnosis of splenic hematoma following splenectomy: 35 cases (2001-2013).

Authors:  Steve G Patten; Sarah E Boston; Gabrielle J Monteith
Journal:  Can Vet J       Date:  2016-08       Impact factor: 1.008

2.  Partial splenectomy for incidentally detected non-ruptured splenic lesions in dogs: 18 cases (2004-2018).

Authors:  Kaustubh R Dongaonkar; Daniel Linden; Jacqueline R Davidson; Harry W Boothe; D Michael Tillson; Brad M Matz
Journal:  Can Vet J       Date:  2019-11       Impact factor: 1.008

3.  Epidemiology and Survival of Dogs Diagnosed with Splenic Lymphoid Hyperplasia, Complex Hyperplasia, Stromal Sarcoma and Histiocytic Sarcoma.

Authors:  Cleide H Spröhnle-Barrera; Jayne McGhie; Rachel E Allavena; Helen C Owen; Chiara Palmieri; Tamsin S Barnes
Journal:  Animals (Basel)       Date:  2022-04-08       Impact factor: 3.231

4.  Development and validation of a multivariable model and online decision-support calculator to aid in preoperative discrimination of benign from malignant splenic masses in dogs.

Authors:  Kristine E Burgess; Lori Lyn Price; Ryan King; Manlik Kwong; Eliza Grant; Katherine A Olson; Jeremiah A Lyons; Nicholas A Robinson; Kristin M Wendelburg; John Berg
Journal:  J Am Vet Med Assoc       Date:  2021-06-15       Impact factor: 1.936

5.  A comparison of microRNA expression profiles from splenic hemangiosarcoma, splenic nodular hyperplasia, and normal spleens of dogs.

Authors:  Janet A Grimes; Nripesh Prasad; Shawn Levy; Russell Cattley; Stephanie Lindley; Harry W Boothe; Ralph A Henderson; Bruce F Smith
Journal:  BMC Vet Res       Date:  2016-12-03       Impact factor: 2.741

6.  Histopathologic characteristics of biopsies from dogs undergoing surgery with concurrent gross splenic and hepatic masses: 125 cases (2012-2016).

Authors:  Fernando J Leyva; Catherine A Loughin; Curtis W Dewey; Dominic J Marino; Meredith Akerman; Martin L Lesser
Journal:  BMC Res Notes       Date:  2018-02-13

7.  Presurgical assessment of splenic tumors in dogs: a retrospective study of 57 cases (2012-2017).

Authors:  Mokhyeon Lee; Jiyoung Park; Hojung Choi; Haebeom Lee; Seong Mok Jeong
Journal:  J Vet Sci       Date:  2018-11-30       Impact factor: 1.672

8.  Prevalence, distribution, and clinical characteristics of hemangiosarcoma-associated skeletal muscle metastases in 61 dogs: A whole body computed tomographic study.

Authors:  Andrea Carloni; Rossella Terragni; Antonio Maria Morselli-Labate; Michaela Paninarova; John Graham; Paola Valenti; Monica Alberti; Giulia Albarello; Francesca Millanta; Massimo Vignoli
Journal:  J Vet Intern Med       Date:  2019-02-22       Impact factor: 3.333

9.  Clinical relevance of splenic nodules or heterogeneous splenic parenchyma assessed by cytologic evaluation of fine-needle samples in 125 dogs (2011-2015).

Authors:  Igor Yankin; Sarah Nemanic; Silvia Funes; Helio de Morais; Elena Gorman; Craig Ruaux
Journal:  J Vet Intern Med       Date:  2019-11-06       Impact factor: 3.333

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.